Different Amounts of Moxibustion in the Treatment of DPN: A Clinical RCT Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

December 31, 2026

Conditions
Diabetic Peripheral NeuropathyPainMoxibustionRandomized Controlled Trial
Interventions
OTHER

Moxibustion

The recruited patients all received diabetes mellitus education. Patients with combined hypertension and hyperlipidemia received daily treatment to lower their blood pressure and blood lipids. The medication was based on their current self-medication, to keep their conditions under normal control. The drug treatment group received mecobalamin tablets and epalrestat orally for four weeks along with their daily treatment. Moxibustion 15-minute group: The selected acupoints of moxibustion are Zusanli(ST 36), Sanyinjiao(SP 6), Quchi(LI 11), and Kunlun(BL 60), moxa cones were pasted on the acupoints and moxibustion was applied by ignition, each time for 15 minutes at each acupoint, once every three days, twice a week, four consecutive weeks of treatment. The moxibustion 30-minute group except for the operating time will use the same intervention as above.

Trial Locations (3)

310000

The First Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou

The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou

Zhejiang Greentown Cardiovascular Hospital, Hangzhou

All Listed Sponsors
collaborator

The First Affiliated Hospital of Zhejiang Chinese Medical University

OTHER

collaborator

Zhejiang Greentown Cardiovascular Hospital

OTHER

lead

Zhejiang Chinese Medical University

OTHER_GOV

NCT06330233 - Different Amounts of Moxibustion in the Treatment of DPN: A Clinical RCT Study | Biotech Hunter | Biotech Hunter